Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Advanced Biomed Inc. ( (ADVB) ).
On July 18, 2025, Advanced Biomed Inc. was notified by Nasdaq that its common stock had failed to meet the $1.00 minimum bid price required for continued listing on the Nasdaq Capital Market, triggering a 180-day compliance period that ended on January 14, 2026. After the company did not regain compliance by that deadline, Nasdaq staff issued a January 16, 2026 letter stating that Advanced Biomed’s securities would be delisted and suspended from trading on January 27, 2026, unless the company appealed; Advanced Biomed appealed on January 21, 2026, which stayed the suspension while it prepares to present a remediation plan, centered on a shareholder-approved reverse stock split expected to take effect on or after February 13, 2026, although there is no assurance the Nasdaq hearings panel will grant continued listing or that compliance will be achieved in time.
More about Advanced Biomed Inc.
Advanced Biomed Inc. is a company whose common stock is listed on the Nasdaq Capital Market, subject to Nasdaq’s continued listing standards, including the $1.00 minimum bid price requirement.
Average Trading Volume: 1,075,034
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.41M
For detailed information about ADVB stock, go to TipRanks’ Stock Analysis page.